Onderneming Compass Therapeutics, Inc.
Aandelen
CMPX
US20454B1044
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,06 USD | 0,00% |
|
-5,36% | -32,05% |
28/05 | Compass Therapeutics, Inc. Kondigt wijzigingen aan in CEO | CI |
28/05 | Compass Therapeutics, Inc. Kondigt wijzigingen in het management aan | CI |
Vakgebied
Aantal werknemers: 32
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 63 | 01-01-14 |
Neil Lerner
DFI | Director of Finance/CFO | 56 | 01-01-20 |
Karin Herrera
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Minori Rosales
CTO | Chief Tech/Sci/R&D Officer | 61 | 01-05-23 |
General Counsel | - | 01-08-21 | |
Ian Chia
PRN | Corporate Officer/Principal | - | 01-01-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Lindahl
BRD | Director/Board Member | 70 | 21-04-23 |
Mary Gray
BRD | Director/Board Member | 71 | 25-04-22 |
Ellen Chiniara
BRD | Director/Board Member | 65 | 25-04-22 |
Carl Gordon
CHM | Chairman | 59 | 01-01-15 |
Phil Ferneau
BRD | Director/Board Member | 62 | 01-01-15 |
Thomas Schuetz
CEO | Chief Executive Officer | 63 | 01-01-14 |
James Boylan
BRD | Director/Board Member | 57 | 01-11-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 137 589 171 | 121 022 398 ( 87,96 %) | 0 | 87,96 % |
Bedrijfsgegevens
![Adres Compass Therapeutics, Inc.(CMPX)](https://cdn.zonebourse.com/static/address/115071909.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-32,05% | 146 mln. | |
+16,49% | 122 mld. | |
+21,73% | 115 mld. | |
+22,42% | 26,64 mld. | |
-21,81% | 19,91 mld. | |
-16,89% | 16,32 mld. | |
-18,81% | 15,49 mld. | |
-44,74% | 15,52 mld. | |
+62,72% | 14,83 mld. | |
+3,09% | 13,67 mld. |
- Beurs
- Aandelen
- Koers CMPX
- Onderneming Compass Therapeutics, Inc.